LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Abrir

SetorSaúde

21.38 1.18

Visão Geral

Variação de preço das ações

24h

Atual

Mín

20.65

Máximo

21.41

Indicadores-chave

By Trading Economics

Rendimento

-5.7M

-12M

Vendas

-2.8M

73M

EPS

0.04

Margem de lucro

-16.197

Funcionários

1,313

EBITDA

-2M

-12M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+15.27% upside

Dividendos

By Dow Jones

Próximos Ganhos

1 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

57M

629M

Abertura anterior

20.2

Fecho anterior

21.38

Sentimento de Notícias

By Acuity

78%

22%

357 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Fulgent Genetics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de jun. de 2025, 20:45 UTC

Ganhos

Broadcom 2Q Sales Climb on Booming AI Demand

5 de jun. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 de jun. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 de jun. de 2025, 23:30 UTC

Conversa de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 de jun. de 2025, 21:32 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jun. de 2025, 20:45 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:24 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Rev $15B >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Net $4.97B >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Adj EPS $1.58 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q EPS $1.03 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom Sees 3Q Rev $15.8B >AVGO

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 de jun. de 2025, 19:22 UTC

Conversa de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 de jun. de 2025, 19:00 UTC

Conversa de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 de jun. de 2025, 18:32 UTC

Conversa de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 de jun. de 2025, 18:26 UTC

Ganhos

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 de jun. de 2025, 18:06 UTC

Conversa de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 de jun. de 2025, 16:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 de jun. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jun. de 2025, 16:18 UTC

Conversa de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 de jun. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

5 de jun. de 2025, 16:12 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

5 de jun. de 2025, 16:12 UTC

Conversa de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 de jun. de 2025, 16:03 UTC

Conversa de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 de jun. de 2025, 15:49 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparação entre Pares

Variação de preço

Fulgent Genetics Inc Previsão

Preço-alvo

By TipRanks

15.27% parte superior

Previsão para 12 meses

Média 24 USD  15.27%

Máximo 25 USD

Mínimo 23 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Fulgent Genetics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

17.32 / 19.04Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Neutral Evidence

Sentimento

By Acuity

357 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.